GE Capital’s Healthcare Financial Services (HFS) business announced
today that it is serving as administrative agent and collateral agent on
a $250 million term loan financing for Amneal Pharmaceuticals LLC. This
term loan will be pari passu with a previously closed $491 million term
loan on which GE Capital is also the administrative agent. GE Capital
Markets served as joint bookrunner on both financings.
Headquartered in Bridgewater, N.J., Amneal is a vertically-integrated
developer, manufacturer, marketer and distributor of generic
pharmaceuticals. It’s among the largest manufacturers of generic
pharmaceuticals in the U.S. The proceeds from this financing will be
used to fund capital expansion related to manufacturing facilities and a
distribution to existing shareholders.
“We value our long-standing relationship with HFS and its deep
understanding of our company and our business,” said Rochelle Fuhrmann,
Amneal’s CFO. “We’re pleased with its focus and execution as well as its
ability to handle the many dynamics that come into play on large
financing deals.”
"We are pleased to have completed this financing for Amneal. It’s the
sixth transaction we’ve successfully agented for the company over the
past several years,” said Al Aria, senior managing director of HFS’
Corporate Finance business. “It further illustrates our ability to
combine our pharmaceutical sector expertise with our capital markets
capabilities to help rapidly growing companies such as Amneal realize
their strategic goals.”
About Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC is a global supplier of generic
pharmaceuticals, vertically integrated across the entire supply chain
from R&D to finished goods. Since its inception in 2002, Amneal has
invested extensively in R&D resources, manufacturing infrastructure, and
strategic expansion opportunities — all contributing to significant
growth. The company prides itself on its unwavering commitment to
quality, strong business relationships, and innovative approach. Amneal
is privately held with U.S. headquarters in Bridgewater, N.J., and
international headquarters in Zug, Switzerland. For more information,
please visit www.amneal.com.
About GE Capital, Healthcare Financial Services
GE Capital’s Healthcare Financial Services (HFS) business is one of the
most active capital providers in the U.S. healthcare market, deploying
approximately $10.5 billion in new commitments to customers via 240+
transactions in 2014. That adds up to more than $80 billion in financing
over the past 11 years. For the third consecutive year, HFS was the top
lead arranger for financings up to $1 billion in U.S. healthcare
leveraged finance.
Customers across 45 healthcare sectors — including senior housing,
hospitals, medical offices, outpatient services, pharmaceuticals and
medical devices — rely on HFS to finance acquisitions, refinance
existing debt, support working capital needs and fund growth
initiatives. With in-depth industry knowledge and expertise, the HFS
team of professionals creates business and financial solutions tailored
to meet the individual needs of its customers. For more information,
visit gecapital.com/healthcare or follow company news via Twitter (http://twitter.com/GELendLease).
GE Capital offers consumers and businesses around the globe an array of
financial products and services. For more information, visit www.gecapital.com
or follow company news via Twitter (http://twitter.com/GECapital).
GE (NYSE:GE) works on things that matter. The best people and the best
technologies taking on the toughest challenges. Finding solutions in
energy, health and home, transportation and finance. Building, powering,
moving and curing the world. Not just imagining. Doing. GE works. For
more information, visit the company's website at www.ge.com.
Copyright Business Wire 2015